You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

135 Results
Drug
Other Name(s): Leukeran®
Nov 2024
Drug
Other Name(s): Femara®
Nov 2020
Drug
Other Name(s): Lederle Leucovorin® (multiple brands available)
Dec 1969
Drug
Other Name(s): Xeloda®
Jul 2024
Drug
Other Name(s): CeeNU®
Dec 1969
Drug
Other Name(s): Procytox®
Dec 1969
Drug
Other Name(s): Somatuline® Autogel®
Dec 1969
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    letrozole
Nov 2020
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    letrozole
Nov 2020
Regimen
Cancer Type:
Central Nervous System
Intent: Palliative
Funding:
ODB - General Benefit
    lomustine
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Adjuvant, Palliative
Funding:
ODB - General Benefit
    capecitabine
Jul 2024
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Intent: Palliative
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer
ODB - General Benefit
    capecitabine

Pages